Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

bioAffinity Technologies (BIAF) Tax Provisions: 2022-2025

Historic Tax Provisions for bioAffinity Technologies (BIAF) over the last 4 years, with Sep 2025 value amounting to $3,182.

  • bioAffinity Technologies' Tax Provisions rose 24.35% to $3,182 in Q3 2025 from the same period last year, while for Sep 2025 it was $43,420, marking a year-over-year increase of 211.41%. This contributed to the annual value of $11,650 for FY2024, which is 44.51% down from last year.
  • bioAffinity Technologies' Tax Provisions amounted to $3,182 in Q3 2025, which was down 89.02% from $28,984 recorded in Q2 2025.
  • Over the past 5 years, bioAffinity Technologies' Tax Provisions peaked at $28,984 during Q2 2025, and registered a low of -$1 during Q4 2022.
  • For the 3-year period, bioAffinity Technologies' Tax Provisions averaged around $7,350, with its median value being $4,130 (2023).
  • In the last 5 years, bioAffinity Technologies' Tax Provisions surged by 229,400.00% in 2023 and then crashed by 68.93% in 2024.
  • bioAffinity Technologies' Tax Provisions (Quarterly) stood at -$1 in 2022, then skyrocketed by 229,400.00% to $2,293 in 2023, then increased by 11.55% to $2,559 in 2024, then climbed by 24.35% to $3,182 in 2025.
  • Its last three reported values are $3,182 in Q3 2025, $28,984 for Q2 2025, and $8,695 during Q1 2025.